Skip to main content
Top
Published in: Drugs & Aging 5/2018

01-05-2018 | Commentary

Clinical Pharmacy Services on Geriatric Care Wards: Catch 22 of Implementation and Research

Authors: Lorenz Van der Linden, Julie Hias, Karolien Walgraeve, Johan Flamaing, Isabel Spriet, Jos Tournoy

Published in: Drugs & Aging | Issue 5/2018

Login to get access

Excerpt

Potentially inappropriate prescribing (PIP) remains prevalent in older adults, whether pertaining to over-, mis-, or under-prescribing [1, 2]. Both polypharmacy and PIP have been correlated with an increased risk of iatrogenic harm such as unplanned hospital admissions [2]. This risk might be mitigated by implementing strategies to reduce PIP. These strategies frequently comprise a comprehensive medication review and the involvement of ward-based clinical pharmacists [35]. …
Literature
1.
go back to reference Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–84.CrossRefPubMed Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–84.CrossRefPubMed
2.
go back to reference Wauters M, Elseviers M, Vaes B, Degryse J, Dalleur O, Vander Stichele R, et al. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. Br J Clin Pharmacol. 2016;82(5):1382–92.CrossRefPubMedPubMedCentral Wauters M, Elseviers M, Vaes B, Degryse J, Dalleur O, Vander Stichele R, et al. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. Br J Clin Pharmacol. 2016;82(5):1382–92.CrossRefPubMedPubMedCentral
3.
go back to reference Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;2:CD008986.PubMed Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;2:CD008986.PubMed
4.
go back to reference Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.CrossRefPubMed Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.CrossRefPubMed
5.
go back to reference Renaudin P, Boyer L, Esteve MA, Bertault-Peres P, Auquier P, Honore S. Do pharmacist-led medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(6):1660–73.CrossRefPubMedPubMedCentral Renaudin P, Boyer L, Esteve MA, Bertault-Peres P, Auquier P, Honore S. Do pharmacist-led medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(6):1660–73.CrossRefPubMedPubMedCentral
6.
go back to reference Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.CrossRefPubMed Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.CrossRefPubMed
7.
go back to reference Hohl CM, Wickham ME, Sobolev B, Perry JJ, Sivilotti ML, Garrison S, et al. The effect of early in-hospital medication review on health outcomes: a systematic review. Br J Clin Pharmacol. 2015;80(1):51–61.CrossRefPubMedPubMedCentral Hohl CM, Wickham ME, Sobolev B, Perry JJ, Sivilotti ML, Garrison S, et al. The effect of early in-hospital medication review on health outcomes: a systematic review. Br J Clin Pharmacol. 2015;80(1):51–61.CrossRefPubMedPubMedCentral
8.
go back to reference Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5:CD008165. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5:CD008165.
9.
go back to reference Johansson T, Abuzahra ME, Keller S, Mann E, Faller B, Sommerauer C, et al. Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(2):532–48.CrossRefPubMedPubMedCentral Johansson T, Abuzahra ME, Keller S, Mann E, Faller B, Sommerauer C, et al. Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(2):532–48.CrossRefPubMedPubMedCentral
10.
go back to reference Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894–900.CrossRefPubMed Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894–900.CrossRefPubMed
11.
go back to reference Van der Linden L, Decoutere L, Walgraeve K, Milisen K, Flamaing J, Spriet I, et al. Combined use of the rationalization of home medication by an Adjusted STOPP in older Patients (RASP) list and a pharmacist-led medication review in very old inpatients: impact on quality of prescribing and clinical outcome. Drugs Aging. 2017;34(2):123–33.CrossRefPubMed Van der Linden L, Decoutere L, Walgraeve K, Milisen K, Flamaing J, Spriet I, et al. Combined use of the rationalization of home medication by an Adjusted STOPP in older Patients (RASP) list and a pharmacist-led medication review in very old inpatients: impact on quality of prescribing and clinical outcome. Drugs Aging. 2017;34(2):123–33.CrossRefPubMed
12.
go back to reference Lavan AH, Gallagher PF, O’Mahony D. Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging. 2016;11:857–66.PubMedPubMedCentral Lavan AH, Gallagher PF, O’Mahony D. Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging. 2016;11:857–66.PubMedPubMedCentral
13.
go back to reference Hazen AC, Sloeserwij VM, Zwart DL, de Bont AA, Bouvy ML, de Gier JJ, et al. Design of the POINT study: pharmacotherapy optimisation through integration of a non-dispensing pharmacist in a primary care Team (POINT). BMC Fam Pract. 2015;2(16):76.CrossRef Hazen AC, Sloeserwij VM, Zwart DL, de Bont AA, Bouvy ML, de Gier JJ, et al. Design of the POINT study: pharmacotherapy optimisation through integration of a non-dispensing pharmacist in a primary care Team (POINT). BMC Fam Pract. 2015;2(16):76.CrossRef
14.
go back to reference Renaudin P, Baumstarck K, Daumas A, Esteve MA, Gayet S, Auquier P, et al. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial. Trials. 2017;18(1):65.CrossRefPubMedPubMedCentral Renaudin P, Baumstarck K, Daumas A, Esteve MA, Gayet S, Auquier P, et al. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial. Trials. 2017;18(1):65.CrossRefPubMedPubMedCentral
15.
go back to reference Gallagher J, O’Sullivan D, McCarthy S, Gillespie P, Woods N, O’Mahony D, et al. Structured pharmacist review of medication in older hospitalised patients: a cost-effectiveness analysis. Drugs Aging. 2016;33(4):285–94.CrossRefPubMed Gallagher J, O’Sullivan D, McCarthy S, Gillespie P, Woods N, O’Mahony D, et al. Structured pharmacist review of medication in older hospitalised patients: a cost-effectiveness analysis. Drugs Aging. 2016;33(4):285–94.CrossRefPubMed
16.
go back to reference Portela MC, Pronovost PJ, Woodcock T, Carter P, Dixon-Woods M. How to study improvement interventions: a brief overview of possible study types. BMJ Qual Saf. 2015;24(5):325–36.CrossRefPubMedPubMedCentral Portela MC, Pronovost PJ, Woodcock T, Carter P, Dixon-Woods M. How to study improvement interventions: a brief overview of possible study types. BMJ Qual Saf. 2015;24(5):325–36.CrossRefPubMedPubMedCentral
17.
go back to reference Pellegrin KL, Krenk L, Oakes SJ, Ciarleglio A, Lynn J, McInnis T, et al. Reductions in medication-related hospitalizations in older adults with medication management by hospital and community pharmacists: a quasi-experimental study. J Am Geriatr Soc. 2017;65(1):212–9.CrossRefPubMed Pellegrin KL, Krenk L, Oakes SJ, Ciarleglio A, Lynn J, McInnis T, et al. Reductions in medication-related hospitalizations in older adults with medication management by hospital and community pharmacists: a quasi-experimental study. J Am Geriatr Soc. 2017;65(1):212–9.CrossRefPubMed
Metadata
Title
Clinical Pharmacy Services on Geriatric Care Wards: Catch 22 of Implementation and Research
Authors
Lorenz Van der Linden
Julie Hias
Karolien Walgraeve
Johan Flamaing
Isabel Spriet
Jos Tournoy
Publication date
01-05-2018
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 5/2018
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-018-0547-1

Other articles of this Issue 5/2018

Drugs & Aging 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine